Video

Appropriately Diagnosing and Classifying Breast Cancer

Transcript:

Joyce A. O’Shaughnessy, MD: Fortunately, most women with breast cancer present in the early stages, found either on their own self-examination or on a mammogram. Most women present with stage 1 or 2 or stage 3 breast cancer, all of which are curable. They don’t have any symptoms, but they maybe notice a mass or sometimes a rapidly growing breast cancer that can be a little uncomfortable. But there’s not much in the way of symptoms.

Unfortunately, metastatic breast cancer generally does present with symptoms. It comes to a woman’s attention because she has bone pain, for example, cough, or sometimes abdominal pain. Metastatic disease that has spread, usually to a vital organ or to a distant site, unfortunately does cause symptoms and those are what brings the breast cancer to attention.

There are 3 broad categories of breast cancer that we use to define the best treatment options for patients. The most common is the estrogen receptor—positive, hormone receptor–positive, HER2-negative [human epidermal growth factor receptor 2–negative] population. That’s about two-thirds of breast cancers. About 15% to 20% of cases are HER2-positive breast cancers, where the HER2 gene becomes amplified, there’s too much HER2, and HER2 is really driving that breast cancer. And lastly, there’s the triple-negative breast cancer, which does not have the estrogen receptor, the progesterone receptor, or HER2 positivity, but generally speaking, it’s a very fast-growing breast cancer. We utilize chemotherapy for that breast cancer. Those are the 3 broad categories of breast cancer that we have.

Transcript Edited for Clarity


Related Videos
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine in the Department of Medicine at Beth Israel Deaconess Medical Center in Boston.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Image of a woman with light shoulder-length hair, wearing rectangular glasses.
Image of man with grey hair.
Image of woman with blonde hair.
Image of woman with brown hair.